DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Sarashina A, Koiwai K, Seman LJ. et al.
Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects.
Drug Metab Pharmacokinet 2013;
28: 213-219
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.